Dyne Therapeutics, Inc logo

Dyne Therapeutics, Inc (DYN)

$30.01

Dyne Therapeutics, Inc (DYN) Share Price Forecast
Currently 13 wall-street analysts regularly analyze the financials of Dyne Therapeutics, Inc on a frequent basis to provide recommendations along with target share price. 13 analysts offering 12-month price forecasts for Dyne Therapeutics, Inc (DYN) have a share price target of $46.89. This median of share price forecast represents a 56.25% upside from the latest price of $30.01 as on 29.05.24.

Dyne Therapeutics, Inc (DYN) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Dyne Therapeutics, Inc (DYN) share price will touch around $46.89 in next 12-months.
Dyne Therapeutics, Inc (DYN) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Dyne Therapeutics, Inc's share price and its median forecast price. As on 29.05.24, the difference is -44.91%

Dyne Therapeutics, Inc (DYN): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Dyne Therapeutics, Inc (DYN) Share Price : Analyst Recommendation
Based on 13 analysts tracking and researching Dyne Therapeutics, Inc (DYN) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
5
6
6
Outperform
6
6
6
Hold
1
1
1
Underperform
0
0
0
Sell
0
0
0
Dyne Therapeutics, Inc (DYN) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Dyne Therapeutics, Inc (DYN) is $46.89, offered by 13 analysts offering 12-month price forecasts.

Dyne Therapeutics, Inc (DYN) has a maximum of 0.56 upside potential, based on 13 analysts offering 12-month price forecasts.

Based on 13 analysts tracking and researching Dyne Therapeutics, Inc (DYN), 92.31% have a buy recommendation. Remaining 7.69% have either sell or hold recommendations.

The latest share price of Dyne Therapeutics, Inc (DYN) is $30.01 as of 29/05/2024.

12 of total 13 analysts offering stock ratings for Dyne Therapeutics, Inc DYN have recommended buy rating.